Thrombosis and Haemostasis · 2007 · 239 citations · 57 references
MedicineBiochemistryPharmacologyBone MetabolismHuman NutritionMineral MetabolismBone Metabolism DisordersOsteoporosisVitamin BiochemistryVitamin K DeficiencyVitamin PhysiologyVitamin SupplementationCalcificationCoagulationCoagulation DysregulationCoagulation EffectsHerbal SupplementsMineral SupplementsVitamin K MetabolismVitamin K Physiology
Vitamin K, first identified in the 1930s, is a cofactor for glutamate carboxylation in coagulation factors and extra‑hepatic proteins such as osteocalcin and matrix Gla protein, and may have additional yet‑unidentified side effects. The study proposes using vitamin K as a dietary supplement or functional food to prevent bone and vascular disease in healthy people and to mitigate coumarin‑induced side effects and INR variability in patients on oral anticoagulants. The authors recommend delivering vitamin K through dietary supplements and functional foods to achieve these protective effects. Incomplete carboxylation of osteocalcin and MGP raises osteoporosis and vascular calcification risk and is common in healthy people, revealing widespread subclinical vitamin K deficiency.
Vitamin K, discovered in the 1930s, functions as cofactor for the posttranslational carboxylation of glutamate residues. Gammacarboxy glutamic acid (Gla)-residues were first identified in prothrombin and coagulation factors in the 1970s; subsequently, extra-hepatic Gla proteins were described, including osteocalcin and matrix Gla protein (MGP). Impairment of the function of osteocalcin and MGP due to incomplete carboxylation results in an increased risk for developing osteoporosis and vascular calcification, respectively, and is an unexpected side effect of treatment with oral anticoagulants. It is conceivable that other side effects, possible involving growth-arrest-specific gene 6 (Gas6) protein will be identified in forthcoming years. In healthy individuals, substantial fractions of osteocalcin and MGP circulate as incompletely carboxylated species, indicating that the majority of these individuals is subclinically vitamin K-deficient. Potential new application areas for vitamin K are therefore its use in dietary supplements and functional foods for healthy individuals to prevent bone and vascular disease, as well as for patients on oral anticoagulant treatment to offer them protection against coumarin-induced side effects and to reduce diet-induced fluctuations in their INR values.
57
Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
Guangbin Luo, Patricia Ducy, Marc D. McKee et al. · Nature · 1997 · 2.1K citations
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
Simone Rost, Andreas Fregin, Vytautas Ivaškevičius et al. · Nature · 2004 · 1.1K citations